HPV typing and its relation with apoptosis in cervical carcinoma from Indian population
- 111 Downloads
Definite progress in understanding the etiology of cervical cancer has been achieved, and some types of human papillomavirus have been established as the central cause of cervical cancer worldwide. This study investigates the human papillomavirus infection and its correlation with apoptosis and clinicopathologic characteristics in squamous cell carcinoma of uterine cervix. Human papillomavirus typing was done by type-specific primers for high-risk human papillomavirus using standard polymerase chain reaction method. Programmed cell death (apoptosis) was determined by terminal deoxynucleotidyl transferase biotin–dUTP nick end labeling assay. Human papillomavirus infection in tissue biopsy of cervical carcinoma was detected in 131 of 135 (97%) cases. Among the positive cases of human papillomavirus, 123 (94%) cases were human papillomavirus type 16, and five (4%) cases were human papillomavirus type 18. Out of 135 cervical carcinoma cases, 81 (60%) cases showed presence of apoptosis. The phenomenon of apoptosis was seen slightly higher in squamous cell carcinoma than in adenocarcinoma (40% in squamous cell carcinoma and 33% in adenocarcinoma). The human papillomavirus infection in cervical cancer might not play any role in the occurrence of apoptosis.
KeywordsHPV Apoptosis Cervical cancer TUNEL assay
The authors acknowledge University Grants Commission (UGC), Government of India, New Delhi, for providing the fund for this study.
- 1.International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, vol 64. Human papillomaviruses. Lyon: IARC; 1995.Google Scholar
- 5.American Cancer Society. Facts & figures 2009. Atlanta: ACS; 2009.Google Scholar
- 6.Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. In: IARC cancer base no. 5, version 2.0 IARC: Lyon; 2004.Google Scholar
- 7.National Cancer Registry Programme. Consolidated report of hospital based cancer registries 2001–2003. ICMR: New Delhi; 2007.Google Scholar
- 15.Current status of development of prophylactic vaccines against human papillomavirus infection. Report of a technical meeting, Geneva, 16–18 February 1999. Department of Vaccines and Biologicals, World Health Organization, and the International Agency for Research on Cancer, Geneva. 1999. http://www.who.int/vaccine_research/documents/en/hpv1.pdf.
- 17.Lowy DR, Schiller JT. Papillomaviruses: prophylactic vaccine prospects. Biochim Biophys Acta. 1998;1423:M1–8.Google Scholar
- 19.Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3rd ed. Plainview: Cold Spring Harbor Lab; 2001.Google Scholar
- 21.Preacher KJ. Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence [computer software]. 2001. http://www.quantpsy.org/chisq/chisq.htm.